New directions in the treatment of opioid withdrawal
- 1 June 2020
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 395 (10241), 1938-1948
- https://doi.org/10.1016/s0140-6736(20)30852-7
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Effect of Iboga Alkaloids on µ-Opioid Receptor-Coupled G Protein ActivationPLOS ONE, 2013
- Opiate-Induced Molecular and Cellular Plasticity of Ventral Tegmental Area and Locus Coeruleus Catecholamine NeuronsCold Spring Harbor Perspectives in Medicine, 2012
- Opioid Detoxification and Naltrexone Induction Strategies: Recommendations for Clinical PracticeThe American Journal of Drug and Alcohol Abuse, 2012
- Using medication-assisted treatment for substance use disorders: Evidence of barriers and facilitators of implementationAddictive Behaviors, 2011
- Pharmacotherapy in the Treatment of Addiction: MethadoneJournal of Addictive Diseases, 2010
- Why do patients report transferring between methadone and buprenorphine?Drug and Alcohol Review, 2009
- Extended vs Short-term Buprenorphine-Naloxone for Treatment of Opioid-Addicted YouthJAMA, 2008
- Self‐treatment of opioid withdrawal using kratom (Mitragynia speciosa korth)Addiction, 2008
- The Novel Anticonvulsant Drug, Gabapentin (Neurontin), Binds to the α2δ Subunit of a Calcium ChannelOnline Journal of Public Health Informatics, 1996
- OUTPATIENT CLONIDINE DETOXIFICATIONThe Lancet, 1981